We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
P5.2
Phosphorus Research
Mostly mechanism / observational
9 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Phosphorus studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality studies published 1981–2023 with a typical study size of 2,191 participants.
Based on 9 studies · 2,191 total participants
Confidence
Low confidence
By outcome
Bone healthPhosphorus is a structural component of bone mineral (hydroxyapatite), but supplementation helps bone only when intake is genuinely deficient; most people get enough from food, and excess can disturb calcium balance · Only relevant in documented deficiency
Too few graded studies2 studies
Therapeutic & clinical
Too few graded studies2 studies
Kidney & renal health
Too few graded studies2 studies
Longevity & aging
Too few graded studies1 study
Active research area
3 studies in the last 5 years
198120022023
1Review2017
In plain English: Rickets is a bone disease associated with abnormal serum calcium and phosphate levels.
Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM · Nature Reviews Disease Primers (2017)
Rickets is caused by nutritional deficiencies or genetic defects affecting vitamin D metabolism, FGF23, renal phosphate handling, or bone mineralization.
The clinical picture includes bowing deformities of the legs, short stature, and widening of joints, varying by age of onset and cause.
Oral phosphate supplementation is usually indicated for FGF23-independent phosphopenic rickets.
In plain English: In humans, 80% of the body phosphorus is present in the form of calcium phosphate crystals (apatite) that confer hardness to bone and teeth, and function as the major phosphorus reservoir.
Peacock M · Calcified Tissue International (2021)
Phosphorus is a key element in organic molecules involved in essential cellular functions: ATP energy transfer, DNA/RNA, cAMP signaling, and glycerophospholipid membrane integrity.
About 80% of body phosphorus resides in bone and teeth as calcium-phosphate apatite, serving as the major reservoir; the remainder is in soft tissue and extracellular fluid.
At physiological pH, inorganic phosphate exists as both H2PO4- and HPO4(2-) and acts as an extracellular-fluid buffer.
In plain English: Although phosphorus is an essential nutrient required for multiple physiological functions, recent research raises concerns that high phosphorus intake could have detrimental effects on health.
Chang AR, Anderson C · Annual Review of Nutrition (2017)
Phosphorus is abundant in the food supply of developed countries, occurring naturally in protein-rich foods and as an additive in processed foods.
High phosphorus intake can cause vascular and renal calcification, renal tubular injury, and premature death in multiple animal models.
Small human studies suggest high phosphorus intake may produce positive phosphorus balance and correlate with renal calcification and albuminuria.
In plain English: Recent findings show that increasing dietary phosphorus through inorganic phosphate additives has detrimental effects on bone and mineral metabolism in humans and animals.
Vorland CJ, Stremke ER, Moorthi RN, Hill Gallant KM · Current Osteoporosis Reports (2017)
The average phosphorus intake in the USA is well above the recommended dietary allowance.
Inorganic phosphate additives are absorbed at a high rate and account for a substantial, likely underestimated, portion of excessive intake.
Phosphate additives have negative effects on bone metabolism and present a prime opportunity to lower total phosphorus intake.
In plain English: FGF23 is an important hormonal regulator of phosphate homeostasis... it modulates phosphate reabsorption... in the renal proximal tubules.
Imel EA, Biggin A, Schindeler A, Munns CF · JBMR Plus (2019)
FGF23, with its co-receptor Klotho, regulates renal phosphate reabsorption and vitamin D hydroxylation.
X-linked hypophosphatemia (XLH), caused by PHEX mutations, is the most common FGF23-mediated hypophosphatemia.
FGF23-mediated hypophosphatemias cannot be cured with nutritional vitamin D and historically required oral phosphate plus active vitamin D analogs.
In plain English: A high-caloric diet or rapid refeeding in children/adolescents suffering from AN may be both safe and effective, with serial laboratory investigations and phosphate supplementation as needed.
Mosuka EM, Murugan A, Thakral A, Ngomo MC, Budhiraja S, St Victor R · Cureus (2023)
Systematic review of 20 full-text studies on high-caloric refeeding protocols in children and adolescents with anorexia nervosa, totaling 2,191 participants.
Hypophosphatemia — the biochemical hallmark of refeeding syndrome — was a central monitored outcome across the included studies.
A lower BMI at hospital admission was a better predictor of hypophosphatemia than total caloric intake.
In plain English: Potentially modifiable risk factors for osteoporosis are vitamin D deficiency... low calcium intake, low or excessive phosphorus intake, protein deficiency or a high-protein diet.
Tański W, Kosiorowska J, Szymańska-Chabowska A · European Review for Medical and Pharmacological Sciences (2021)
Osteoporosis affects over 200 million people worldwide and is defined by low bone mineral density (T-score ≤ -2.5).
Both low AND excessive phosphorus intake are listed among modifiable dietary risk factors for osteoporosis — underscoring that balance, not more, is what protects bone.
Other modifiable risks include vitamin D deficiency, low calcium intake, smoking, alcohol, and a sedentary lifestyle.
In plain English: We present recommendations for phosphate repletion in CRRT to prevent hypophosphatemia, and describe our experience using phosphate-containing CRRT solutions.
Heung M, Mueller BA · Seminars in Dialysis (2018)
Hypophosphatemia is a common, under-recognized complication of continuous renal replacement therapy (CRRT) in critically ill patients.
Continuous filtration removes phosphate, and without repletion patients readily become hypophosphatemic.
The review provides practical recommendations for phosphate repletion during CRRT.
In plain English: An increase in dietary phosphorus greatly reduces urinary calcium by increasing the fractional renal tubular reabsorption of calcium.
Linkswiler HM, Zemel MB, Hegsted M, Schuette S · Federation Proceedings (1981)
Under controlled diets, the level of dietary protein has a profound, sustained effect on urinary calcium and calcium retention.
Young adults reached calcium balance at 500 mg calcium and 700-1,000 mg phosphorus when protein intake was 50 g.
Increasing dietary phosphorus reduces urinary calcium loss by raising renal tubular calcium reabsorption — illustrating the tight phosphorus-calcium interrelationship.